About GHK-Cu (Copper Tripeptide-1) GHK-Cu is not a new compoundit has been studied for decades
Products are not intended for human or animal use
By pairing this knowledge with a commitment to using only the highest-purity research compounds, you set the stage for discovery
Looking for expert support and inclusive learning options
Suggested table of clinical case studies (to include in article): columns for patient phenotype (age, BMI, diagnosis), peptide used (dose, duration), metabolic outcomes (weight change, HOMA-IR), reproductive outcomes (ovulation, oocyte yield, pregnancy), adverse events, and follow-up duration, such as PCOS, obesity-associated anovulation, poor ovarian response, and metabolic syndrome